From the Journals

Obesity and weight loss both linked to RA disability


 

FROM ARTHRITIS CARE & RESEARCH

“Therefore, while intentional weight loss might be expected to have direct beneficial effects with regard to physical functioning and disability, these benefits are likely to be outweighed by the more common scenario of unintentional weight loss in association with greater severity of chronic illness,” they wrote. Indeed, one of the two registries used in the study had previously found a strong correlation between weight loss and early risk of death.

They argued that this therefore still supported – rather than refuted – the accepted view that intentional weight loss was an important way to limit disability in people with rheumatoid arthritis.

One limitation of the study was the use of BMI to measure adiposity, which the authors suggested may not have been an accurate surrogate in people with chronic disease. They also acknowledged that measures of disease activity may be different between obese and nonobese patients, and adjusting for this was challenging.

Three authors acknowledged receiving grand awards from the U.S. Department of Veterans Affairs. No conflicts of interest were declared.

SOURCE: Baker J et al. Arthritis Care Res. 2018 Apr 30. doi: 10.1002/acr.23579.

Pages

Recommended Reading

Tocilizumab raises cholesterol, but not cardiovascular events
MDedge Cardiology
No rise in CV events seen with tocilizumab
MDedge Cardiology
VIDEO: Cardiovascular events in rheumatoid arthritis have decreased over decades
MDedge Cardiology
VIDEO: Prescription-strength ibuprofen worsens blood pressure more than other NSAIDs
MDedge Cardiology
Rheumatoid arthritis characteristics make large contribution to cardiovascular risk
MDedge Cardiology
Health disparities in rural America: Chronic conditions
MDedge Cardiology
JAK inhibitors for RA: Is VTE risk overblown?
MDedge Cardiology
NIAID proposes 3-pronged plan for universal influenza vaccine
MDedge Cardiology
Few acutely ill hospitalized patients receive VTE prophylaxis
MDedge Cardiology
FDA advisory committee votes to recommend update to celecoxib safety labeling
MDedge Cardiology

Related Articles